On January 21, 2025, the European Health Data Space Regulation (EHDS) was formally adopted by the Council of the European Union. This marks the near-final step in the adoption process, and the text will be published in the coming weeks. Importantly for life sciences companies (pharma, biotech, and medtech), the EHDS’ so-called secondary use provisions
Latest Post
More Posts
European Regulator Clarifies Guidance on the Use of AI in the Medicinal Product Lifecycle
Top Trends in the European Digital Health/AI Market
EU, U.S., and UK Regulatory Developments on the Use of Artificial Intelligence in the Drug Lifecycle
European Parliament’s Position on the AI Act Moots Significant Changes
EU Moving Closer to an AI Act – Key Areas of Impact for Life Sciences/MedTech Companies
Subscribe: Subscribe via RSS
Blogs
Firm/Org